Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bio Essence (BIOE) Receivables - Net (2020 - 2025)

Bio Essence has reported Receivables - Net over the past 6 years, most recently at $23454.0 for Q4 2025.

  • For Q4 2025, Receivables - Net rose 357.73% year-over-year to $23454.0; the TTM value through Dec 2025 reached $23454.0, up 357.73%, while the annual FY2025 figure was $23454.0, 357.73% up from the prior year.
  • Receivables - Net for Q4 2025 was $23454.0 at Bio Essence, up from $4969.0 in the prior quarter.
  • Over five years, Receivables - Net peaked at $143164.0 in Q4 2023 and troughed at $4969.0 in Q2 2025.
  • A 5-year average of $31652.7 and a median of $20858.0 in 2021 define the central range for Receivables - Net.
  • On a YoY basis, Receivables - Net climbed as much as 398.82% in 2024 and fell as far as 96.42% in 2024.
  • Year by year, Receivables - Net stood at $16820.0 in 2021, then surged by 136.88% to $39843.0 in 2022, then surged by 259.32% to $143164.0 in 2023, then tumbled by 96.42% to $5124.0 in 2024, then soared by 357.73% to $23454.0 in 2025.
  • Business Quant data shows Receivables - Net for BIOE at $23454.0 in Q4 2025, $4969.0 in Q3 2025, and $4969.0 in Q2 2025.